Back to results
US 2018/0193495 A1Published application
Positron emitting radionuclide labeled peptides for human upar pet imaging
AssigneeCurasight Aps
InventorsAndreas Kjaer, Morten Persson, Jacob Madsen
Life of this patent
Estimating the term…
Abstract
There is provided a positron-emitting radionuclide labelled peptide for non-invasive PET imaging of the Urokinase-type Plasminogen Activator Receptor (uPAR) in humans. More specifically the invention relates to human uPAR PET imaging of any solid cancer disease for diagnosis, staging, treatment monitoring and especially as an imaging biomarker for predicting prognosis, progression and recurrence.
Claims5
A conjugate comprising a positron-emitting radionuclide labelled peptide, wherein said conjugate comprises a uPAR binding peptide coupled via NOTA, to a 68Ga radionuclide.
Dependencies are inferred from the claim text.